Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
ProShares UltraPro Dow 30
UDOW
$924M
| $18.4M | ﹤0.01% |
718,400
-285,200
| -28% | -$6.35M |
|
1802
Wayfair
W
$13.9B
| $18.4M | ﹤0.01% |
81,453
-87,513
| -52% | -$23.2M |
|
1803
iShares Core S&P Mid-Cap ETF
IJH
$129B
| $18.4M | ﹤0.01% |
399,865
+215,980
| +117% | +$9.1M |
|
1804
CALL
TG Therapeutics
TGTX
$7.46B
| $18.4M | ﹤0.01% |
352,900
+37,600
| +12% | +$1.27M |
|
1805
Lufax Holding
LU
$1.3B
| $18.4M | ﹤0.01% |
+323,127
| New | +$19.3M |
|
1806
CALL
Consolidated Edison
ED
$40.2B
| $18.3M | ﹤0.01% |
253,700
-56,600
| -18% | -$4.4M |
|
|
FSR
1807
DELISTED
Fisker Inc.
FSR
| $18.3M | ﹤0.01% |
1,249,998
-274,537
| -18% | -$4.04M |
|
1808
PUT
HDFC Bank
HDB
$120B
| $18.3M | ﹤0.01% |
505,400
-44,400
| -8% | -$1.42M |
|
|
ISEE
1809
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $18.2M | ﹤0.01% |
2,636,319
+1,434,972
| +119% | +$9.18M |
|
1810
PUT
Cracker Barrel
CBRL
$1.29B
| $18.2M | ﹤0.01% |
137,900
+3,500
| +3% | +$450K |
|
1811
CALL
Baxter International
BAX
$13.8B
| $18.2M | ﹤0.01% |
226,700
+46,200
| +26% | +$3.66M |
|
1812
PUT
Hasbro
HAS
$13.6B
| $18.2M | ﹤0.01% |
194,300
+24,900
| +15% | +$2.21M |
|
1813
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $18.2M | ﹤0.01% |
269,100
-176,600
| -40% | -$11.7M |
|
1814
CALL
Cadence Design Systems
CDNS
$89.5B
| $18.1M | ﹤0.01% |
133,000
+10,700
| +9% | +$1.26M |
|
|
TWOU
1815
PUT
DELISTED
2U Inc
TWOU
| $18.1M | ﹤0.01% |
15,113
+66
| +0.4% | +$70.8K |
|
|
SKX
1816
DELISTED
Skechers
SKX
| $18.1M | ﹤0.01% |
504,057
+413,299
| +455% | +$14.1M |
|
1817
CALL
StoneCo
STNE
$2.32B
| $18.1M | ﹤0.01% |
215,800
+18,200
| +9% | +$1.22M |
|
1818
PUT
BioMarin Pharmaceuticals
BMRN
$13B
| $18.1M | ﹤0.01% |
206,100
-124,800
| -38% | -$9.89M |
|
|
NNDM
1819
PUT
Nano Dimension
NNDM
$344M
| $18.1M | ﹤0.01% |
+1,985,600
| New | +$10.1M |
|
|
RDS.A
1820
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $18M | ﹤0.01% |
513,392
-392,608
| -43% | -$12.3M |
|
1821
CALL
Arrowhead Research
ARWR
$12.2B
| $18M | ﹤0.01% |
234,900
+36,000
| +18% | +$2.3M |
|
1822
CALL
Corsair Gaming
CRSR
$1.41B
| $18M | ﹤0.01% |
+497,600
| New | +$15.2M |
|
1823
CALL
Royal Gold
RGLD
$19.5B
| $18M | ﹤0.01% |
169,100
-55,200
| -25% | -$6.38M |
|
1824
Casey's General Stores
CASY
$31.3B
| $18M | ﹤0.01% |
100,639
+19,997
| +25% | +$3.63M |
|
1825
PUT
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $17.9M | ﹤0.01% |
8,925
-120
| -1% | -$191K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.